124 related articles for article (PubMed ID: 19608620)
21. Non-alcoholic steatohepatitis mimicking liver metastasis in obesity surgery.
Mansour S; Hou D; Rattan R; Wan A
Dig Endosc; 2011 Oct; 23(4):316-8. PubMed ID: 21951092
[TBL] [Abstract][Full Text] [Related]
22. Hyaline-vascular type of Castelman's disease associated with Crohn's disease.
Yavasoglu I; Kadikoylu G; Meteoglu I; Bolaman Z
Int J Colorectal Dis; 2009 Jan; 24(1):123-4. PubMed ID: 18682964
[No Abstract] [Full Text] [Related]
23. Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.
Lebovics E; Rubin J
Diabetes Metab Res Rev; 2011 Jul; 27(5):419-24. PubMed ID: 21425426
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors for pure steatosis in alcoholic patients.
Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
[TBL] [Abstract][Full Text] [Related]
25. Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.
Akbar DH; Kawther AH
Med Sci Monit; 2006 Jan; 12(1):RA23-6. PubMed ID: 16369477
[TBL] [Abstract][Full Text] [Related]
26. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
27. [Non-alcoholic fatty liver].
Bhala N; Usherwood T; George J
Praxis (Bern 1994); 2010 Feb; 99(3):187-9. PubMed ID: 20127639
[No Abstract] [Full Text] [Related]
28. A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.
Anty R; Iannelli A; Patouraux S; Bonnafous S; Lavallard VJ; Senni-Buratti M; Amor IB; Staccini-Myx A; Saint-Paul MC; Berthier F; Huet PM; Le Marchand-Brustel Y; Gugenheim J; Gual P; Tran A
Aliment Pharmacol Ther; 2010 Dec; 32(11-12):1315-22. PubMed ID: 21050233
[TBL] [Abstract][Full Text] [Related]
29. How should we manage patients with non-alcoholic fatty liver disease in 2007?
Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
[TBL] [Abstract][Full Text] [Related]
30. Nonalcoholic fatty liver disease.
Bayard M; Holt J; Boroughs E
Am Fam Physician; 2006 Jun; 73(11):1961-8. PubMed ID: 16770927
[TBL] [Abstract][Full Text] [Related]
31. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.
Vilar L; Oliveira CP; Faintuch J; Mello ES; Nogueira MA; Santos TE; Alves VA; Carrilho FJ
Nutrition; 2008; 24(11-12):1097-102. PubMed ID: 18640006
[TBL] [Abstract][Full Text] [Related]
32. Silent non-alcoholic fatty liver disease-a clinical-histological study.
Sorrentino P; Tarantino G; Conca P; Perrella A; Terracciano ML; Vecchione R; Gargiulo G; Gennarelli N; Lobello R
J Hepatol; 2004 Nov; 41(5):751-7. PubMed ID: 15519647
[TBL] [Abstract][Full Text] [Related]
33. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
Tilg H; Moschen A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
[TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
Tiniakos DG
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
[TBL] [Abstract][Full Text] [Related]
35. The range of normal values of liver enzymes in the era of metabolic syndrome: the need for a redefinition.
Perés Wingeyer SD; de Larrañaga GF; Belli SH; Graffigna MN; Fainboim H
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):589-91. PubMed ID: 18467923
[No Abstract] [Full Text] [Related]
36. [Nonalcoholic steatohepatitis: epidemiology, diagnosis and treatment].
Tilg H
Dtsch Med Wochenschr; 2001 Apr; 126(16):467-71. PubMed ID: 11360453
[No Abstract] [Full Text] [Related]
37. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
Federico A; Trappoliere M; Loguercio C
Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of non-alcoholic fatty liver disease].
Koek GH
Ned Tijdschr Geneeskd; 2011; 155():A3181. PubMed ID: 21649947
[TBL] [Abstract][Full Text] [Related]
39. [Fatigue and pollakisuria].
Bucheli B; Lehmann K
Praxis (Bern 1994); 1998 Apr; 87(18):636-8. PubMed ID: 9623336
[No Abstract] [Full Text] [Related]
40. Relationship between nonalcoholic fatty liver disease and metabolic syndrome.
Chen SH; He F; Zhou HL; Wu HR; Xia C; Li YM
J Dig Dis; 2011 Apr; 12(2):125-30. PubMed ID: 21401898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
